Veritas Capital has acquired Coronis Health and MiraMed Global Services
Coronis Health and MiraMed
Coronis Health is a leading provider of end-to-end revenue cycle management (RCM) solutions to U.S. healthcare providers including primary and specialty physician practices, anesthesia groups, laboratories, emergency medical services, behavioral health centers, federally qualified health centers and hospitals. Since its founding in 2015, Coronis has rapidly become an industry leader with an emphasis on quality, transparency and customer satisfaction. Coronis’ solutions address the full RCM continuum for a patient’s journey, allowing clients to focus on delivering high-quality patient care to the communities they serve.
Founded by Tony and Sue Mira in 1979, MiraMed is a leading provider of end-to-end RCM and business process outsourcing services for anesthesia practices and commercial healthcare clients in the United States. MiraMed delivers medical coding, billing and receivables management solutions to regional, anesthesia-focused physician practices and other commercial healthcare clients, supported by a highly strategic hybrid onshore / offshore delivery model.
Veritas Capital, a leading technology and government investor with deep healthcare expertise, announced that an affiliate of Veritas has completed the combination of two complementary RCM businesses: Coronis and MiraMed Global Services. Veritas acquired Coronis from 424 Capital and other minority shareholders. Veritas acquired MiraMed from the Mira family, who will retain an ownership position in the combined company. The combination creates a scaled RCM platform providing end-to-end technology-enabled solutions to a diverse set of healthcare providers across the United States. The newly combined company benefits from meaningfully increased scale, end-to-end RCM capabilities across multiple specialties and robust infrastructure with more than 8,500 employees globally.
Veritas is a longstanding technology investor with a focus on companies operating at the intersection of technology and government. The firm invests in companies that provide critical products, software and services, primarily technology and technology-enabled solutions, to government and commercial customers worldwide. Veritas seeks to create value by strategically transforming the companies in which it invests through organic and inorganic means.
Leveraging technology to make a positive impact across vitally important areas, such as healthcare, education and national security, is core to Veritas. It is a proud stewards of national assets, improving the quality of healthcare while reducing cost, advancing the educational system and protecting the nation and allies. For more information, please visit www.veritascapital.com.
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International advised Varsity Healthcare Partners on the sale of Angels of Care Pediatric Home Health to Nautic Partners
Lincoln International advised Aquiline Capital Partners on the acquisition of Health Prime from GPB Capital Holdings
Lincoln International advised Talisman Capital Partners on the sale of ADVOCATE RCM to Ventra Health, a portfolio company of Varsity Healthcare Partners
Lincoln International advised Mars on the sale of Diamond Animal Health to Veterinary Pharmaceutical Solutions, a portfolio company of Granite Creek Capital Partners
Lincoln International advised 7Mind on its sale to Gymondo, a portfolio company of Oakley Capital
Lincoln International advised Olive AI on the sale of substantially all of its assets to Waystar and Humata Health
Lincoln International advised EQT on the acquisition of a controlling stake in Indira IVF from TA Associates and promoter family
Lincoln International advised Scantox Group, a portfolio company of Impilo, on its acquisition of QPS Austria’s Neuropharmacology Division
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.